Severe methylenetetrahydrofolate reductase deficiency: Clinical clues to a potentially treatable cause of adult-onset hereditary spastic paraplegia

JAMA Neurology

Volumn 71, Issue 7, 2014, Pages 901-904

  Lossos, Alexander ^a   Teltsh, Omri ^b,c   Milman, Tsipi ^b   Meiner, Vardiella ^a   Rozen, Rima ^d   Leclerc, Daniel ^d   Schwahn, Bernd C ^d   Karp, Natalya ^d   Rosenblatt, David S ^d   Watkins, David ^d   Shaag, Avraham ^a   Korman, Stanley H ^a   Heyman, Samuel N ^a   Gal, Aya ^a   Newman, J P ^a   Steiner Birmanns, Bettina ^d,e   Abramsky, Oded ^a   Kohn, Yoav ^b,d,f  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^b HEBREW UNIVERSITY   (Israel)

^c BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^d MCGILL UNIVERSITY   (Canada)

^e SHAARE ZEDEK MEDICAL CENTER   (Israel)

^f Jerusalem Mental Health Center Ezrath Nashim   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE OF ONSET; AGED; BETAINE; FEMALE; HOMOCYSTINURIA; HUMANS; LIPOTROPIC AGENTS; MAGNETIC RESONANCE IMAGING; MALE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MIDDLE AGED; MUSCLE SPASTICITY; PROSPECTIVE STUDIES; PSYCHOTIC DISORDERS; SEVERITY OF ILLNESS INDEX; SPASTIC PARAPLEGIA, HEREDITARY; TREATMENT OUTCOME;

EID: 84905450992     PISSN: 21686149     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamaneurol.2014.116     Document Type: Article

References (12)

1. Finsterer J, Löscher W, Quasthoff S, Wanschitz J, Auer-Grumbach M, Stevanin G. Hereditary spastic paraplegias with autosomal dominant, recessive, X-linked, or maternal trait of inheritance. J Neurol Sci. 2012;318(1-2):1-18.
2. Goyette P, Christensen B, Rosenblatt DS, Rozen R. Severe and mild mutations in cis for the methylenetetrahydrofolate reductase (MTHFR) gene, and description of five novel mutations in MTHFR. Am J Hum Genet. 1996;59(6):1268-1275. (Pubitemid 26394118)
3. Haworth JC, Dilling LA, Surtees RAH, et al. Symptomatic and asymptomatic methylenetetrahydrofolate reductase deficiency in two adult brothers. Am J Med Genet. 1993;45(5):572-576. (Pubitemid 23066418)
4. Schwarz JM, Rödelsperger C, Schuelke M, Seelow D. MutationTaster evaluates disease-causing potential of sequence alterations. Nat Methods. 2010;7(8):575-576.
5. Pasquier F, Lebert F, Petit H, Zittoun J, Marquet J. Methylenetetrahydrofolate reductase deficiency revealed by a neuropathy in a psychotic adult. J Neurol Neurosurg Psychiatry. 1994;57(6):765-766. (Pubitemid 24182975)
6. Michot JM, Sedel F, Giraudier S, Smiejan JM, Papo T. Psychosis, paraplegia and coma revealing methylenetetrahydrofolate reductase deficiency in a 56-year-oldwoman. J Neurol Neurosurg Psychiatry. 2008;79(8):963-964.
7. Birnbaum T, Blom HJ, Prokisch H, Hartig M, Klopstock T. Methylenetetrahydrofolate reductase deficiency (homocystinuria type II) as a rare cause of rapidly progressive tetraspasticity and psychosis in a previously healthy adult. J Neurol. 2008;255(11):1845-1846.
8. Selzer RR, Rosenblatt DS, Laxova R, Hogan K. Adverse effect of nitrous oxide in a child with 5,10-methylenetetrahydrofolate reductase deficiency. N Engl J Med. 2003;349(1):45-50. (Pubitemid 36765102)
9. Arai M, Osaka H. Acute leukoencephalopathy possibly induced by phenytoin intoxication in an adult patient with methylenetetrahydrofolate reductase deficiency. Epilepsia. 2011;52(7):e58-e61.
10. Surtees R, Leonard J, Austin S. Association of demyelination with deficiency of cerebrospinal-fluid S-adenosylmethionine in inborn errors of methyl-transfer pathway. Lancet. 1991;338(8782-8783):1550-1554.
11. Strauss KA, Morton DH, Puffenberger EG, et al. Prevention of brain disease from severe 5,10-methylenetetrahydrofolate reductase deficiency. Mol Genet Metab. 2007;91(2):165-175. (Pubitemid 46765173)
12. Tallur KK, Johnson DA, Kirk JM, Sandercock PAG, Minns RA. Folate-induced reversal of leukoencephalopathy and intellectual decline in methylene- tetrahydrofolate reductase deficiency: variable response in siblings. Dev Med Child Neurol. 2005;47(1):53-56. (Pubitemid 40163968)